Mediastinal lymphadenopathy in COVID-19: A review of literature  

作　　者：Pahnwat Tonya Taweesedt Salim Surani 

机构地区：[1]Department of Medicine,Corpus Christi Medical Center,Corpus Christi,TX 78404,United States [2]Department of Pulmonary Critical Care and Sleep Medicine,Texas A and M Health Science Center,Bryan,TX 77807,United States

出　　处：《World Journal of Clinical Cases》2021年第12期2703-2710,共8页世界临床病例杂志

摘　　要：A novel coronavirus disease 2019(COVID-19)is a progressive viral disease that affected people around the world with widespread morbidity and mortality.Patients with COVID-19 infection typically had pulmonary manifestation but can also present with gastrointestinal,cardiac,or neurological system dysfunction.Chest imaging in patients with COVID-19 commonly show bilateral lung involvement with bilateral ground-glass opacity and consolidation.Mediastinal lymphadenopathy can be found due to infectious or non-infectious etiologies.It is commonly found to be associated with malignant diseases,sarcoidosis,and heart failure.Mediastinal lymph node enlargement is not a typical computer tomography of the chest finding of patients with COVID-19 infection.We summarized the literature which suggested or investigated the mediastinal lymph node enlargement in patients with COVID-19 infection.Further studies are needed to better characterize the importance of mediastinal lymphadenopathy in patients with COVID-19 infection.

关 键 词：Mediastinal lymphadenopathy Lymph node enlargement COVID-19 Novel corona virus Long term coronavirus disease-sequala Coronavirus disease complications 

分 类 号：R563.1[医药卫生—呼吸系统] R564[医药卫生—内科学]